Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reirradiation and Hyperthermia With or Without Cisplatin for Locoregional Recurrent Breast Cancer
2010-019225-33Phase 2Terminated
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cisplatin in breast cancer (2 arms). Primary endpoint: local control rate. Started Apr 2010; status: terminated.
02
Drugs
cisplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2010-019225-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019225-33.